Incredible Nasdaq Company Hovering Around $1 Per Share With Aggressive Rollup Strategy

​ [Biotech Stock Market News] [Newly Announced Acquisition Reveals Strategic Rollup - Nasdaq Company Navigating The $315Bn Diagnostics Sector]( The global market for laboratory services is poised for significant growth. This sector is currently valued at $202Bn. Experts predict that it could surge to over $315Bn by 2030. What is fueling this momentum? The increasing demand for diagnostic tests and the rise in chronic diseases particularly in developed regions. Get ready to learn more about an incredible under-the-radar company trading on the Nasdaq that recently revealed their rollup strategy to position themselves at the front of this enormous $315Bn diagnostics sector. Key Highlights: This profile has a low float with approx 8Mn+ shares available (Volatility Watch). They are strategically aiming to dominate the expanding lab test market by acquiring a leading diagnostics company. Their strong intellectual property foundation is highlighted by collaborations with MIT. Don't miss out on researching this incredible up and coming prospect that you have in front of you right now. [Click Here to Reveal the Company!]( Notice: Please understand that by opting out from future emails from this advertiser, you are transferring or authorizing the transfer of your email address to the advertiser listed above. Zacks has no control over how your email address is used by the advertiser or other third parties. Accordingly, Zacks disclaims all responsibility and liability arising from the subsequent use of your email address that is made possible by your submission of your email address above. You are receiving this email from Zacks Investment Research because you chose to receive messages from Zacks’ partners on the Zacks web site(s). Please note that Zacks does not produce or endorse this product, and assumes no responsibility for the use thereof. Your privacy is important to us. Click here to see our Privacy Policy: [( If you do not wish to receive further email solicitations from Zacks on behalf of its partners, please click [here]( to unsubscribe. Zacks Investment Research 10 S. Riverside Plaza, Suite 1600 Chicago, IL 60606